Sumitomo Pharma Co., Ltd. (DNPUF) Discusses R&D Progress, Oncology Pipeline, and Advances in Regenerative Medicine and Vaccines Transcript
Source: SeekingAlpha
2026-02-20 18:25:02 ET
Sumitomo Pharma Co., Ltd. (DNPUF) Discusses R&D Progress, Oncology Pipeline, and Advances in Regenerative Medicine and Vaccines February 17, 2026 12:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Sumitomo Pharma Co., Ltd. (DNPUF) Discusses R&D Progress, Oncology Pipeline, and Advances in Regenerative Medicine and Vaccines Transcript
Sumitomo Pharma Co. Ltd. ADR - 865614101
NASDAQ: SMDPY
SMDPY Trading
0.0% G/L:
$12.44 Last:
1,370 Volume:
$12.44 Open:
